SUMMARY Complete congenital heart block is associated with the presence of maternal autoantibodies to small ribosomal nucleoproteins (such as anti-Ro) which cross the placenta and may be deposited at the site ofcardiac damage. Ten such cases ofcongenital heart block, their mothers, and their siblings were studied. The seropositive mother of one case had a similar conduction defect (bifascicular block) to that in her affected child. None of the siblings examined had cardiac lesions. Six mothers had Ro or La antibody five to 17 years after the birth of the affected child. Four mothers examined 11-32 years after the birth ofan affected child were seronegative. Three ofthese mothers had evidence ofa connective tissue disorder. This evidence is consistent with a hypothesis that a maternal viral infection, associated with autoantibody production, leads to virus crossing the placenta, damaging the fetal heart, and eliciting local deposition of maternal antibody. Table 1 gives the clinical details of the 10 cases (five male and five female patients). Six of them had had permanent pacemakers inserted. One was diagnosed in utero, four were identified in the neonatal period, and the others at ages from 18 months to 20 years. 
The development of complete congenital heart block is associated with the transplacental passage of matemal autoantibodies directed at small ribosomal nucleoproteins. " Most mothers who give birth to an affected infant have anti-Ro or the related anti-La serum antibody, as do their infants up to three months after birth.'34 Immunoglobulins thought to be ofmaternal origin were found at the site ofcardiac damage in one baby who died three days after birth.2
A mother who gives birth to such an infant may or may not have a connective tissue disease at the time, but 30-60% of these women will develop such an illness subsequently."5 There are, however, several unanswered questions-for example, what is the risk of subsequent offspring being affected? Are the two sexes at equal risk (affected males tend to have complete congenital heart block only while affected females show other stigmata of the neonatal lupus syndrome3), and, because the antibody seems to produce such severe damage to fetal myocardium, what is its long term effect on adult heart tissue?
To try and answer these questions we investigated 10 individuals who had this isolated cardiac abnormality and their mothers. Family studies of congenital heart block associated with RO antibody Center for Disease Control, Atlanta; the center also severe dermatomyositis and rheumatoid arthritis supplied anti-La, anti-nRNP, and anti-Sm antisera respectively before any of their children were born.
(antisera to related nuclear antigens). Control sera The other mothers (of cases 8, 9 and 10) developed were obtained from a group of 40 pregnant women, arthritis after the birth of the affected infant. The age-matched for the mothers tested. mother of case 7 had rheumatic fever aged 12 years The Ouchterlony plates were examined at 24, 48, and since then has taken prophylactic antibiotics 72, and 96 hours. The counterimmunoelectro-before any dental procedure. phoresis plates were left overnight at room
Only the mother of case 1, who has been taking temperature, then washed in 5% citrate for four prednisolone 5 mg per day for the past 12 years, hours, in saline for 48 hours, and stained with complained of cardiac symptoms-she had exerCoomassie blue.
tional dyspnoea. Detailed questioning elicited no complaints from the other mothers. None was hyperResults tensive. Eight underwent electrocardiography and echocardiography. The mother of case 8 was too Table 2 shows the results of examining the mothers. anxious to attend for investigation while the mother Their ages at the time of birth of the affected child (aged 71 years) ofcase 10 had fallen and was unable to ranged from 22 years to 43 years. They are currently attend the hospital. The only abnormality detected was in the mother (aged 38) of case 2, who was a non-smoker and who had partial right bundle branch block with left axis deviation. She had no evidence of ischaemic heart disease. Five mothers had Ro antibody, when tested five to 17 years after delivery and one had La antibody, at 16 years after delivery. Four mothers, examined at 11 to 32 years later, were seronegative. Two years previously the same results had been found. Six mothers had a connective tissue disease with positive serology. The mothers of cases 1 and 7 had high titres (1/1000) of antinuclear antibodies, and the mother of case 7 also had DNA antibodies, indicative of systemic lupus erythematosus. Five mothers (of cases 1, 3, 4, 8, and 9) had sera positive for rheumatoid factor. None had antibodies to the related extractable nuclear antigens, Sm or nRNP.
The affected individuals (cases 5 to 10) were themselves tested for the same panel of antibodies and were, as expected, all negative. Table 3 shows the family relationships. Each case of congenital heart block had one or more siblings. The older ones had been examined by a cardiologist at the time the index case was diagnosed and none was found to have any evidence of cardiac disease. Four families had children born after the affected child, from one to eight years later, and all of these had undergone cardiac evaluation with electrocardiograms and had been found to be normal. The other six patients were the youngest in their families; the births of three of them were preceded by miscarriages.
We looked at three generations in the family ofone patient (case 9) who was herself seronegative as expected. She recently gave birth to a healthy son.
Discussion
Complete congenital heart block is a rare cardiac lesion, occurring as an isolated finding, in approxi- which may be exclusively associated with Ro but no other autoantibodies.' Since then, it has been postulated that the maternal autoantibody actually causes the cardiac damage, because maternal immunoglobulin, with or without complement, was found in the hearts of affected infants."' Two questions immediately arise. What is the risk to the child of a mother who is seropositive for antiRo and what may be the long term effect of the antibody on the mother herself? In attempting to answer them, we concluded that the antibody itself cannot be the damaging agent although it may provide a clue to the pathogenesis.
Our group of mothers was typical of those previously described, with specific antibodies in six mothers and three of the four seronegative women having developed a connective tissue disease. They were tested 11-32 years after the birth of an affected child, which may explain their seronegativity. One mother did not have any positive immunological results but she is only 36 years old.
An unexpected finding, not previously recorded in any such mothers, was that of partial right bundle branch block with left axis deviation, indicating bifascicular conduction damage, in the mother of case 2. She was an energetic, normotensive woman of 38, a non-smoker, with no evidence of ischaemic heart disease but this result showed that she had evidence of conduction damage similar to that of her middle son. None of the other seven women had any abnormality, although the connective tissue disorders, which four of them had, are known to be associated with such cardiac lesions. These were dermatomyositis,"' 7 rheumatoid arthritis,'8 and systemic lupus erythematosus.'9 It is plain, therefore, that even in predisposed mothers, the Ro antibody may be present for up to 17 years without causing any injury to the maternal conduction system.
As for the risk to the child ofa seropositive mother, all our cases had unaffected siblings-older, younger, or both. Four children, the younger siblings of cases 2, 5, 6, and 9 were undoubtedly exposed to maternal Ro antibody, while others (of cases 1, 8, 9, and 10) are likely to have been at risk. The mother of case 1 had had severe dermatomyositis (a disorder in which Ro antibodies may appear'7) since before the birth ofany of her three children, while the other mothers were each delivered of a stillbirth immediately before the birth of their affected infant. Ro antibody is undoubtedly associated with fetal loss."20 In summary, the ten mothers had a total of 30 pregnancies with at least 18 fetuses exposed to Ro antibody: 10 developed heart block, three died, and five were unaffected healthy infants.
Similar anomalous findings have been reported before. They include the birth ofdizygous twins, one affected and one not, and three healthy mother and infant anti-Ro seropositive pairs among 300 randomly selected pregnancies."'32' The explanations advanced previously have included possible fluctuations in antibody titre, differing maternal-fetal histocompatibility antigens3' and a hormonal effect, because female infants are more commonly affected,3" but none of these has been substantiated.
The most telling facts against Ro antibody being the cause of the damage, however, are that first, the antigen against which it is directed is present not only in cardiac conduction tissue but in virtually every mammalian cell,2' including fetal tissue at [16] [17] [18] weeks' gestation2' (the earliest stage at which heart block has been detected). Secondly, since Ro is intracellular it should not elicit an immunemediated attack-although there is a possibility that it could appear on Purkinje cell membranes at a critical developmental stage. 2' We would like to suggest a simple explanation for the anomalies in our study and those of others, namely that, before or during the early stage of pregnancy, the mother sustains a mild, perhaps unrecognised viral infection, to which she produces Ro or La antibodies. The virus crosses the placenta and damages the infant myocardium while specific maternal antibody, also crossing the placenta, localises in the same area. The infection in the child is selflimiting but it may persist in the mother so that a series ofinfants are affected. The mother's own heart may also be damaged (see case 2). An obvious viral candidate is a Coxsackie virus, since these viruses are common causes of myocarditis,'5 show considerable sequence homology with certain intracellular proteins,'2 and may persist in connective tissue diseases-for example dermatomyositis'7 (see case 1).
